// App-Quantinova.ai

AEP657 : The impact of variations in laboratory measurements of IGF-1 and random growth hormone on the classification of acromegaly disease activity status: Lessons from the UK Acromegaly Register Reference Laboratory

Researchers

Presenter

  • Bilal Bashir

Principal Investigators

  • Safwaan Adam

  • Philip Monaghan

  • Zoe Plummer

  • Natasha Archer

  • John Ayuk

  • Peter Trainer

Medical Centers

  • The Christie NHS Foundation TRUST, Manchester, United Kingdom

  • Manchester Academic Health Science Centre, St Mary's Hospital, Manchester, United Kingdom

  • The Christie Pathology Partnership, Manchester, United Kingdom

  • Society For Endocrinology, Bristol, United Kingdom

  • University Hospitals Birmingham NHS Foundation Trust, Birmingham, United Kingdom

  • University of Birmingham, Birmingham, United Kingdom

Locations

  • United Kingdom

Companies

  • N/A

Study Components

Therapeutic Area

  • Endocrine/metabolic Diseases (ME)

Disease

  • Acromegaly

Biomarkers

  • Growth Hormone 1

  • Insulin-like growth factor 1

Drug/Treatment

  • hGH

  • Mecasermin

Outcome

  • N/A

Study Design

  • Controlled

Phase

  • NA

Study Id's

  • N/A

Sponsors

  • N/A

Result

  • N/A

Copyright © 2026. QuantiNova All rights reserved